Cardiac Myosin-Binding Protein C as Alternative to Cardiac Troponin T for the Diagnosis of Acute Myocardial Infarction in the Very Early Phase

Cardiac Myosin-Binding Protein C: How a Novel Biomarker Could Transform Chest Pain Triage

“…The potential advantages are compelling: as most patients presenting with chest pain do not have AMI, the goal must be to rule-out AMI in as many patients as possible at the earliest opportunity -in other words, with the first blood draw. Even better, if this could be facilitated in a prehospital setting, where cMyC seems to benefit from dynamic release kinetics [25]. cMyC might allow earlier rule-out of AMI [22] and if the promise of more effective triage holds true up to a fifth of all patients could benefit from expedited discharge or care where necessary.…”